Improving Cardiovascular Outcomes in T2DM: Personalizing Antihyperglycemic Therapy
Credit(s): 1.00 (60 min)
Release Date: Aug 31, 2021
Expiration Date: Aug 31, 2022
CME / AMA PRA Category 1 Credit™
MIPS Improvement Activity Under MACRA
Physicians – prescribed AAFP Credit(s)
Physicians/ABIM MOC – ABIM MOC Point(s)
Approximately 13% of the US adult population has diabetes, with the majority (95%) having type 2 diabetes mellitus (T2DM). Cardiovascular disease (CVD) is the number one cause of death for patients with T2DM. The pathophysiology of T2DM contributes to atherogenesis and has a direct effect on the myocardium.
The cardiovascular effects of newer antihyperglycemic drugs have been studied in prospective cardiovascular outcomes trials, while information from older agents comes from observational studies and meta-analyses. These data led many societies to publish updated guidelines on the management of patients with T2DM with or at high risk for CVD, incorporating the cardiovascular effects of antihyperglycemic agents.
The educational program Improving Cardiovascular Outcomes in T2DM: Personalizing Antihyperglycemic Therapy will familiarize primary care physicians with the pathophysiology of CVD in T2DM, results of cardiovascular outcomes trials of antihyperglycemics, and recommendations from several societies regarding the use of these agents in patients with T2DM who have or are at risk for CVD.
Jointly provided by the Potomac Center for Medical Education and Rockpointe
Education resources provided in collaboration with Health Union LLC
This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck & Co., Inc. and Novo Nordisk.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.